Publications by authors named "Nathan Fowler"

Claim this Profile
M
MutAnt: mutation annotation tool predicts deleteriousness of missense mutations and improves mutation calling from transcriptomics.
Aleksandr Sarachakov, Anastasiya Yudina, Viktor Svekolkin, Anna Parfenenkova, Miryam Spektor, Nathan Fowler

Hum Genet· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mutational and copy number analysis at diagnosis and relapse of mantle cell lymphoma.
Erel Joffe, Manik Uppal, Serena Zheng, Kurt S Bantilan, Connie Batlevi, Nathan Fowler

Haematologica· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 2 study of obinutuzumab combined with lenalidomide in previously untreated high tumor burden follicular lymphoma.
Neha Akkad, Lei Feng, Jason R Westin, Fredrick B Hagemeister, Hun Ju Lee, Nathan H Fowler

Blood Adv· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
AI-driven multimodal algorithm predicts immunotherapy and targeted therapy outcomes in clear cell renal cell carcinoma.
Danil Stupichev, Natalia Miheecheva, Ekaterina Postovalova, Yang Lyu, Akshaya Ramachandran, Nathan Fowler

Cell Rep Med· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrative genomic analysis of DLBCL identifies immune environments associated with bispecific antibody response.
Sravya Tumuluru, James K Godfrey, Alan Cooper, Jovian Yu, Xiufen Chen, Nathan Fowler

Blood· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Moving T‑Cell Therapies into the Standard of Care for Patients with Relapsed or Refractory Follicular Lymphoma: A Review.
Nathan Hale Fowler, Julio C Chavez, Peter A Riedell

Target Oncol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and activity of lenalidomide in combination with obinutuzumab in patients with relapsed indolent non-Hodgkin lymphoma: a single group, open-label, phase 1/2 trial.
Ashwath Gurumurthi, Collin K Chin, Lei Feng, Nathan H Fowler, Paolo Strati

EClinicalMedicine· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Moving T-Cell Therapies into the Standard of Care for Patients with Relapsed or Refractory Follicular Lymphoma: A Review.
Nathan Hale Fowler, Julio C Chavez, Peter A Riedell

Target Oncol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comprehensive peripheral blood immunoprofiling reveals five immunotypes with immunotherapy response characteristics in patients with cancer.
Daniiar Dyikanov, Aleksandr Zaitsev, Tatiana Vasileva, Iris Wang, Arseniy A Sokolov, Nathan Fowler

Cancer Cell· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Durable response after tisagenlecleucel in adults with relapsed/refractory follicular lymphoma: ELARA trial update.
Martin Dreyling, Nathan Hale Fowler, Michael Dickinson, Joaquin Martinez-Lopez, Arne Kolstad

Blood· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrative genomic analysis identifies unique immune environments associated with immunotherapy response in diffuse large B cell lymphoma.
Sravya Tumuluru, James K Godfrey, Alan Cooper, Jovian Yu, Xiufen Chen, Nathan Fowler

bioRxiv· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of ibrutinib in combination with rituximab and lenalidomide in previously untreated follicular and marginal zone lymphoma: An open label, phase 2 study.
Max J Gordon, Lei Feng, Paolo Strati, Hun Ju Lee, Fredrick B Hagemeister, Nathan H Fowler

Cancer· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative efficacy and safety of tisagenlecleucel and axicabtagene ciloleucel among adults with r/r follicular lymphoma.
Michael Dickinson, Joaquin Martinez-Lopez, Etienne Jousseaume, Hongbo Yang, Xinglei Chai, Nathan Fowler

Leuk Lymphoma· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multi-omic profiling of follicular lymphoma reveals changes in tissue architecture and enhanced stromal remodeling in high-risk patients.
Andrea J Radtke, Ekaterina Postovalova, Arina Varlamova, Alexander Bagaev, Maria Sorokina, Nathan Fowler

Cancer Cell· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Procrustes is a machine-learning approach that removes cross-platform batch effects from clinical RNA sequencing data.
Nikita Kotlov, Kirill Shaposhnikov, Cagdas Tazearslan, Madison Chasse, Artur Baisangurov, Nathan Fowler

Commun Biol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune-depleted tumor microenvironment is associated with poor outcomes and BTK inhibitor resistance in mantle cell lymphoma.
Preetesh Jain, Krystle Nomie, Nikita Kotlov, VitaIy Segodin, Holly Hill, Nathan Fowler

Blood Cancer J· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prolonged cytopenia following CD19 CAR T cell therapy is linked with bone marrow infiltration of clonally expanded IFNγ-expressing CD8 T cells.
Paolo Strati, Xubin Li, Qing Deng, Mario L Marques-Piubelli, Jared Henderson, Nathan H Fowler

Cell Rep Med· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
B-Cell Infiltrate in the Tumor Microenvironment Is Associated With Improved Survival in Resected Lung Adenocarcinoma.
Ibiayi Dagogo-Jack, Ivan Valiev, Nikita Kotlov, Anna Belozerova, Aleksandra Lopareva, Nathan Fowler

JTO Clin Res Rep· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Smart Start: Rituximab, Lenalidomide, and Ibrutinib in Patients With Newly Diagnosed Large B-Cell Lymphoma.
Jason Westin, R Eric Davis, Lei Feng, Fredrick Hagemeister, Raphael Steiner, Nathan Fowler

J Clin Oncol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of tisagenlecleucel in adult Japanese patients with relapsed or refractory follicular lymphoma: results from the phase 2 ELARA trial.
Noriko Fukuhara, Koji Kato, Hideki Goto, Tajima Takeshi, Mayu Kawaguchi, Nathan Fowler

Int J Hematol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of Healthcare Resource Utilization and Hospitalization Costs in Patients With Relapsed or Refractory Follicular Lymphoma Undergoing CAR-T Cell Therapy With Tisagenlecleucel: Results From the ELARA Study.
Nathan Hale Fowler, Michael Dickinson, Monalisa Ghosh, Andy I Chen, Charalambos Andreadis

Transplant Cell Ther· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy comparison of tisagenlecleucel vs usual care in patients with relapsed or refractory follicular lymphoma.
Gilles Salles, Stephen J Schuster, Martin Dreyling, Luca Fischer, John Kuruvilla, Nathan H Fowler

Blood Adv· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targetable vulnerability of deregulated FOXM1/PLK1 signaling axis in diffuse large B cell lymphoma.
Fang Yu, Hua He, Loretta J Nastoupil, Zijun Y Xu-Monette, Ky Pham, Nathan H Fowler

Am J Cancer Res· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multiregional single-cell proteogenomic analysis of ccRCC reveals cytokine drivers of intratumor spatial heterogeneity.
Natalia Miheecheva, Ekaterina Postovalova, Yang Lyu, Akshaya Ramachandran, Alexander Bagaev, Nathan Fowler

Cell Rep· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of a Brief Foster Parent/ Case Worker Training to Support Relationship Building Skills and Acceptance of LGBTQ+ Youth in Care.
Amy M Salazar, Susan E Barkan, Leah F Rankin, Cossette B Woo, Ivana Rozekova, Nathan E Fowler

J Public Child Welf· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis